Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with
Tags :Slider
Pregnolia, a femtech startup, has raised CHF 2.2 million in another round of financing. The company has developed a device for measuring cervical stiffness in pregnant women, an important parameter in predicting spontaneous premature births. The
Nanogence closed its Series A financing round, securing financing from a consortium of investors. The consortium was led by CirCap, an investment platform providing strategic private capital to innovative companies in climate-tech, healthcare and education,
Baker McKenzie Switzerland advised Arab Bank Switzerland on its acquisition of the Quarz’Up project, a first-class, multifunctional commercial development project in Vernier near Geneva in a share deal. The Quarz’Up project will be
Competition & Antitrust
Corporate
Lenz & Staehelin: Vencora announces PTO for Crealogix publicly held
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
bitvoodoo and Communardo Group have combined their businesses to further expand their solutions footprint across Germany, Austria and Switzerland. The two Atlassian Platinum Solution Partners are merging under the umbrella of the Communardo Group. Both
Man Group, a UK-based worldwide investment management company, has just completed its acquisition of a 51% participation in Asteria Investment Managers, a Geneva-based, ESG-oriented asset manager, from the Italian private bank Fideuram – Intesa Sanpaolo Private Banking.
Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
The insurer AXA has acquired the successful Swiss fleet manager CarNet. AXA intends to gradually integrate CarNet Management into its subsidiary for mobil
Highlight Event and Entertainment, which is listed on the SIX Swiss Exchange, has completed a rights offering with net proceeds of CHF 41.2 million. The new shares were subscribed by or placed with existing shareholders, several
